why choose us

Clinical Trials Search

Showing 10,290 of 132,963 result(s)
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

Status: Completed

Condition: Advanced Solid Tumors

Interventions: Oral tablets

Date: 2023-07-12

90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia

Status: Completed

Condition: Carcinoma, Hepatocellular

Interventions: Transarterial Radioembolization

Date: 2023-07-12

Study to Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC)

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions: The study includes 3 parts: Part 1 Dose escalation.
Part 2 Dose Finding non-randomized and Part 3 Dose expansion randomized.

Date: 2023-07-12

Otago Exercise Program Applied By Telerehabilitation

Status: Completed

Condition: Older People--Abuse of

Interventions: telerehabilitation otago exercise program

Date: 2023-07-12

Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.

Status: COMPLETED

Condition: Anesthesia

Interventions: Insertion of a BD NRFit™ spinal needle and optional BD NRFit™ Spinal Introducer Needle using a BD NRFit™ Syringe to perform the neuraxial procedure.

Date: 2023-07-12

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Status: Completed

Condition: Metastatic Uveal Melanoma

Interventions: Dosed orally, twice daily

Date: 2023-07-12

Outpatient Administration of Teclistamab for Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: - Participants will receive the recommended dosage of Teclistamab according to the TECVAYLI™ USPI (step-up dosing followed by weekly treatment dosing)

Date: 2023-07-12

A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

Status: Completed

Condition: Schizophrenia

Interventions: MK-5720 IM injection

Date: 2023-07-12

Outcomes of Pulmonary Valve Replacement With the INSPIRIS (Model 11500A) Valve

Status: Completed

Condition: Heart Valve Prosthesis

Interventions: Aortic Valve

Date: 2023-07-12

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Status: NOT_YET_RECRUITING

Condition: Ovarian Cancer

Interventions: Decitabine is classified as hypomethylation agents.
It works by helping the bone marrow produce normal blood cells and by killing abnormal cells

Date: 2023-07-12